Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2010-04-27
2010-11-02
Gambel, Phillip (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S130100, C424S133100, C424S141100, C424S143100, C424S152100, C424S173100, C530S387100, C530S387300, C530S388100, C530S388200, C530S388220, C530S388700
Reexamination Certificate
active
07824684
ABSTRACT:
This invention relates to anti-P-selectin antibodies and, in particular, to anti-P-selectin antibodies and variants thereof that contain an Fc part derived from human origin and do not bind complement factor C1q. These antibodies have new and inventive properties causing a benefit for a patient suffering from critical limb ischemia or peripheral arterial occlusive disease (CLI/PAOD).
REFERENCES:
patent: 4783399 (1988-11-01), Oldstone et al.
patent: 5800815 (1998-09-01), Chestnut et al.
patent: 7317091 (2008-01-01), Lazar et al.
patent: 7563441 (2009-07-01), Graus et al.
patent: 2006/0024298 (2006-02-01), Lazar et al.
patent: 93/06863 (1993-04-01), None
patent: 03/074679 (1993-09-01), None
patent: 93/21956 (1993-11-01), None
patent: 94/25067 (1994-11-01), None
patent: 94/29351 (1994-12-01), None
Geng et al., J. Bio. Chem., 266, pp. 22323-22318 (1991).
European Journal of Immunology, vol. 24, No. 10.01 (Oct. 1994), pp. 2542-2547, XP000567079.
Journal of Virology, vol. 75, No. 24 (Dec. 2001) pp. 12161-12168, XP002339184.
Reddy et al., Journal of Immuno., 164, pp. 1925-1993 (2000).
Journal of Immunology, vol. 164 (2000) pp. 4178-4184, XP002965858.
Morgan et al., Immunology, 86(2) 319-324 (1995).
Graus Yvo
Himber Jacques
Jansen-Molenaar Miranda
Kling Dorothee
Kopetzki Erhard
Gambel Phillip
Hoffmann-La Roche Inc.
Johnston George W.
Remy Brian C.
Tramaloni Dennis P.
LandOfFree
Methods of inhibiting the binding of P-selectin to PSGL-1... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of inhibiting the binding of P-selectin to PSGL-1..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of inhibiting the binding of P-selectin to PSGL-1... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4152231